BioResource in Adult Infectious Diseases
https://www.ucl.ac.uk/infection-immunity/research/research-department-infection/lab-research-groups/infection-clinical-research-hub/portfolio
The Bioresource for Adult Infectious Diseases (BioAID) is a collaborative project between multiple NHS Hospitals in partnership with closely affiliated UK Universities. BioAID aims to collect biological samples and clinical information from 10,000 episodes in which patients present to hospital with a suspected infectious disease. Participants will be asked to give consent to have their samples and clinical information collected within BioAID. The samples will be used to obtain RNA and serum from blood samples at various time points during the illness. In addition, the samples will be used to obtain the participants DNA and the microbial organism causing the illness where possible. This will provide an invaluable BioResource to evaluate new strategies for diagnosis of infectious diseases and predicting the outcome of specific diseases in individual patients. BioAID will also help to establish the framework for research sampling and data collection to complement existing studies in infectious diseases, and inform the design of new studies as well as provision of NHS services for infectious diseases. The samples and clinical information collected within BioAID will be held within the participating sites. Access to these collections will be provided to research investigators under the terms of material and data sharing agreements. Identifiable patient information will not be disclosed.
Services
- Ability to recontact
Existing samples:
- Suspected infectious disease (situation)
Contact Information
- Email:
- m.noursadeghi@ucl.ac.uk
- Address:
-
Cruciform Building
Division of Infection & Immunnity
London
Greater London
WC1E 6BT
England
Last Updated: 04/23/2020
Annual Statistics
Year | Access Requests Received | Access Requests Approved | ||||
---|---|---|---|---|---|---|
Internal | External | Commercial | Internal | External | Commercial | |
2015 | N/A | N/A | N/A | N/A | N/A | N/A |
2016 | N/A | N/A | N/A | N/A | N/A | N/A |
2017 | N/A | N/A | N/A | N/A | N/A | N/A |
2018 | N/A | N/A | N/A | N/A | N/A | N/A |
2019 | N/A | N/A | N/A | N/A | N/A | N/A |
2020 | N/A | N/A | N/A | N/A | N/A | N/A |
2021 | N/A | N/A | N/A | N/A | N/A | N/A |
2022 | N/A | N/A | N/A | N/A | N/A | N/A |
2023 | N/A | N/A | N/A | N/A | N/A | N/A |
2024 | N/A | N/A | N/A | N/A | N/A | N/A |